@article{10902/37704,
year = {2025},
month = {4},
url = {https://hdl.handle.net/10902/37704},
abstract = {The purpose of this document is to establish SEPAR's official position on the use of high-flow nasal cannula (HFNC) therapy in the home management of patients with chronic respiratory diseases. This position statement is deemed necessary considering current evidence regarding HFNC use in chronic respiratory conditions, with the objective of standardizing its application. This consensus was developed by a panel of experts comprising specialists with established expertise in chronic respiratory failure and high-flow nasal cannula therapy. The panel of experts stablished recommendations in COPD, bronchiectasis, interstitial lung diseases, palliative care, rehabilitation, and chronic treatment settings.},
publisher = {Elsevier Doyma},
publisher = {Archivos de Bronconeumología, 2025, 010, 1-9},
title = {SEPAR position paper on the use of high flow nasal cannula therapy in the home setting},
author = {Moreno-Zabaleta, Raúl and Luján, Manuel and Sayas Catalán, Javier and García Torres, Pedro and López-Padilla, Daniel and Mosteiro Añón, Mar and Martí Beltrán, Sergi and Sanz, Ana and González Martínez, Mónica and Mediano, Olga},
}